Disposition of 15000 shares by Sean Flynn of Vericel Corp at 52.18 subject to Rule 16b-3

VCEL Stock  USD 59.10  2.39  4.21%   
About 63% of all Vericel Corp's institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that some traders are interested. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
  
Filed transaction by Vericel Corp Ord Officer: Chief Legal Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  
Disposition of 15000 common stock at 52.18 of Vericel Corp by Sean Flynn on 16th of July 2024. This event was filed by Vericel Corp Ord with SEC on 2024-07-16. Statement of changes in beneficial ownership - SEC Form 4

Vericel Corp Ord Current Investor Sentiment

Panic Vs Confidence

63

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Vericel Corp's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Vericel Corp Ord.

Vericel Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vericel Corp Fundamental Analysis

We analyze Vericel Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Vericel Corp is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Vericel Corp Ord Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vericel Corp stock to make a market-neutral strategy. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with similar companies.

Peers

Vericel Corp Related Equities

XFORX4 Pharmaceuticals   8.82   
0%
100.0%
IDYAIdeaya Biosciences   4.15   
0%
47.0%
CYTKCytokinetics   3.52   
0%
39.0%
DAWNDay One   3.45   
0%
39.0%
PLRXPliant Therapeutics   3.11   
0%
35.0%
MREOMereo BioPharma   2.79   
0%
31.0%
MRUSMerus BV   2.43   
0%
27.0%
CMRXChimerix   2.33   
0%
26.0%
IPSCCentury Therapeutics   1.61   
0%
18.0%
XNCRXencor   1.60   
0%
18.0%
SNDXSyndax Pharmaceuticals   1.60   
0%
18.0%
STOKStoke Therapeutics   1.15   
0%
13.0%
BPMCBlueprint Medicines   0.98   
0%
11.0%
CLGNCollplant Biotechnologies   0.95   
0%
10.0%
TERNTerns Pharmaceuticals   0.88   
0%
9.0%
RVMDRevolution Medicines   0.53   
0%
6.0%
RLAYRelay Therapeutics   0.43   
4.0%
0%
KROSKeros Therapeutics   0.55   
6.0%
0%
DYNDyne Therapeutics   0.87   
9.0%
0%
CRNXCrinetics Pharmaceuticals   1.77   
20.0%
0%
RGNXRegenxbio   4.67   
52.0%
0%
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
0.08
Revenue Per Share
4.685
Quarterly Revenue Growth
0.27
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.